# LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer

> **NCT06778512** · — · RECRUITING · sponsor: **The First Affiliated Hospital of Guangzhou Medical University** · enrollment: 2500 (estimated)

## Conditions studied

- Lung
- Lung Cancer
- Cancer
- NSCLC

## Interventions

- **OTHER:** Using tissue and peripheral blood proteomics to distinguish the benign and malignant nature of lung cancer in patients, as well as to evaluate therapeutic efficacy and long-term prognosis during the t

## Key facts

- **NCT ID:** NCT06778512
- **Lead sponsor:** The First Affiliated Hospital of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-06-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2025-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06778512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06778512, "LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06778512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*